Our cardiology courses offer up-to-date information on hypercholesterolemia topics such as PCSK9 inhibitors, navigating payer systems, and the latest data from recent publications and cardiology conferences. Select a cardiology medical education activity below to learn more.
In this activity, expert faculty will discuss barriers to the prescription of PCSK9Is and ways to overcome said barriers. The program will conclude with tools and resource recommendations that may be useful in facilitating access to this therapeutic option for the treatment of elevated LDL-C.
James Underberg, MS, MD, FACPM, FACP, FASH, FASPC, FNLA; Mary Katherine Cheeley, PharmD, BCPS, CLS; and Winston Wong, PharmD, provide discussion of the obstacles to prescribing PCSK9Is and solutions for overcoming these barriers. The program will also provide tools and resources that will prove useful in facilitating access to this essential treatment option for patients with elevated LDL-C.